Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine

Journal of Microbiology and Biotechnology

Volumn 13, Issue 1, 2003, Pages 9-14

  Bae, Eun Ah ^a   Kim, Na Young ^a   Han, Myung Joo ^a   Choo, Min Kyung ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Compound K; Cytotoxicity; Ginsenosides; Lactic acid bacteria

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; PRODRUG; PROTOPANAXADIOL 20 GLUCOSIDE; UNCLASSIFIED DRUG; WATER;

ANAEROBIC FERMENTATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; BIOTRANSFORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG TRANSFORMATION; GINSENG; HUMAN; HUMAN CELL; INCUBATION TIME; INTESTINE FLORA; LACTIC ACID BACTERIUM; MALE; MOUSE; NONHUMAN; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TUMOR CELL LINE;

ANIMALIA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM CUNICULI; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM MINIMUM; PANAX GINSENG;

EID: 0037300761     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Akao, T., M. Kanaoka, and K. Kobashi. 1998. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249.
2. Akao, T., H. Kida, M. Kanaoka, M. Hattori, and K. Kobashi. 1998. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50: 1155-1160.
3. Bae, E.-A., S.-Y. Park, and D.-H. Kim. 2000. Constitutive β-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23: 1481-1485.
4. Bae, E. A., M. J. Han, M.-K. Choo, S.-Y. Park, and D.-H. Kim. 2002. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25: 58-63.
5. Carmichael, J., W. G. DeGreff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res. 47: 936-940.
6. Hasegawa, H., J.-W. Sung, and Y. Benno. 1997. Role of human intestinal Prevotella oris in hydrolyzing Ginseng saponis. Planta Medica 63: 436-440.
7. Kanaoka, M., H. Kato, F. Shimada, and S. Yano. 1992. Studies on the enzyme immunoassay of bioactive constituents contained in oriental medicinal drugs. VI. Enzyme immunoassay of ginsenoside Rb1 from Panax ginseng. Chem. Pharm. Bull. 40: 314-317.
8. Kanaoka, M., T. Akao, and K. Kobashi. 1994. Metabolism of ginseng saponins, ginsenosides, by human intestinal bacteria. J. Tradit. Med. 11: 241-245.
9. Karikura, M., T. Miyaze, H. Tanizawa, T. Taniyzma, and Y. Takino. 1991. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside Rb1 and Rb2 in the digestive tract of rats. Chem. Pharm. Bull. 38: 2357-2361.
10. Kim, D.-W., H.-J. Hwang, and K.-H. Park. 2001. Physiological responses of oxygen-tolerant anaerobic Bifidobacterium longum under oxygen. J. Microbiol. Biotechnol. 11: 443-451.
11. Lee, S. J., J. H. Sung, S. J. Lee, C. K. Moon, and B. H. Lee. 1999. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett. 144: 39-43.
12. Lee, K.-H., G. S. Moon, J.-Y. An, H. J. Lee, H. C. Chang, D. K. Chung, J. H. Lee, and J. K. Kim. 2002. Isolation of nisin-producing Lactobacillus lactis strain from Kimchi and characterization of its nisZ gene. J. Microbiol. Biotechnol. 12: 389-397.
13. Mochizuki, M., C. Y. Yoo, K. Matsuzawa, K. Sato, I. Saiki, S. Tono-oka, K. Samukawa, and I. Azuma. 1995. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside Rg3, of Red ginseng. Biol. Pharm. Bull. 18: 1197-1202.
14. Tanaka, N., O. Tanaka, and S. Shibata. 1972. Chemical studies on the oriental plant drugs. XXVIII. Saponins and sapogenins of ginseng; Stereochemistry of sapogenin of ginsenoside Rb1, Rb2 and Rc. Chem. Pharm. Bull. 20: 1212-1216.
15. Sato, K., M. Mochizuki, I. Saiki, Y. C. Yoo, K. Samukawa, and I. Azuma. 1994. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng - ginsenoside Rb2. Biol. Pharm. Bull. 17: 635-639.
16. Wakabayashi, C., H. Hasegawa, J. Murata, and I. Saiki. 1998. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol. Res. 9: 411-417.
17. Wu, J. Y., B. H. Gardner, C. I. Murphy, J. R. Seals, C. R. Kensil, J. Recchia, G. A. Beltz, G. W. Newman, and M. J. Newman. 1992. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 148: 1519-1525.